Detection of trisomy 9 mosaicism in the second trimester screening by abnormal level of biochemical markers
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Trisomy 9 is a rare chromosomal abnormality that occurs in both mosaic and non-mosaic states. The present study reports a case of mosaic trisomy 9 detected during pregnancy in a 41-year-old woman in the second trimester screening. Maternal serum screening results were used to diagnose a chromosomal abnormality in utero. The results were validated by karyotyping. High levels of alpha-fetoprotein and low levels of unconjugated estriol (uE3), human chorionic gonadotropin (hCG), and inhibin A indicate a high risk for chromosomal abnormalities, including trisomy 18. Amniotic fluid karyotyping revealed 47, XX, +9 (30)/46, XX (20) in the fetus. Because a high level (60%) of mosaicism for trisomy 9 in the fetus can affect many parts of the body, the pregnancy was terminated. It seems that a significant reduction in the levels of hCG and uE3 is an informative marker for the detection of chromosomal abnormalities such as trisomy 9.
Abstract
Trisomy 9 is a rare chromosomal abnormality that occurs in both mosaic and non-mosaic states. The present study reports a case of mosaic trisomy 9 detected during pregnancy in a 41-year-old woman in the second trimester screening. Maternal serum screening results were used to diagnose a chromosomal abnormality in utero. The results were validated by karyotyping. High levels of alpha-fetoprotein and low levels of unconjugated estriol (uE3), human chorionic gonadotropin (hCG), and inhibin A indicate a high risk for chromosomal abnormalities, including trisomy 18. Amniotic fluid karyotyping revealed 47, XX, +9 (30)/46, XX (20) in the fetus. Because a high level (60%) of mosaicism for trisomy 9 in the fetus can affect many parts of the body, the pregnancy was terminated. It seems that a significant reduction in the levels of hCG and uE3 is an informative marker for the detection of chromosomal abnormalities such as trisomy 9.
참고문헌 (19)
- Feingold M, "A case of trisomy 9", J Med Genet, 10, pp.184~187 (1973)
- Ma N, "Case report : detection of fetal trisomy 9 mosaicism by multiple genetic testing methods : report of two cases", Front Genet, 14, pp.1121121~ (2023)
- McDuffie RS Jr, "Complete trisomy 9 : case report with ultrasound findings", Am J Perinatol, 11, pp.80~84 (1994)
- Chen CP, "Second-trimester diagnosis of complete trisomy 9 associated with abnormal maternal serum screen results, open sacral spina bifida and congenital diaphragmatic hernia, and review of the literature", Prenat Diagn, 24, pp.455~462 (2004)
- Bruns D, "Presenting physical characteristics, medical conditions, and developmental status of long-term survivors with trisomy 9 mosaicism", Am J Med Genet A, 155A, pp.1033~1039 (2011)
- Canick JA, "Second trimester serum markers", Semin Perinatol, 29, pp.203~208 (2005)
- Younesi S, "Karyotype analysis of amniotic fluid cells and report of chromosomal abnormalities in 15, 401 cases of Iranian women", Sci Rep, 11, pp.19402~ (2021)
- Lam YH, "Low second-trimester maternal serum human chorionic gonadotrophin in a trisomy 9 pregnancy", Prenat Diagn, 18, pp.1212~ (1998)
- Liu Y, "Amniotic fluid karyotype analysis and prenatal diagnosis strategy of 3117 pregnant women with amniocentesis indication", J Comp Eff Res, 12, pp.e220168~ (2023)
- Lu S, "Detection rates of abnormalities in over 10, 000amniotic fluid samples at a single laboratory", BMC Pregnancy Childbirth, 23, pp.102~ (2023)
- Hay SB, "ACOG and SMFM guidelines for prenatal diagnosis : is karyotyping really sufficient?", Prenat Diagn, 38, pp.184~189 (2018)
- Qian G, "Chromosome microarray analysis combined with karyotype analysis is a powerful tool for the detection in pregnant women with high-risk indicators", BMC Pregnancy Childbirth, 23, pp.784~ (2023)
- Hao M, "The difference between karyotype analysis and chromosome microarray for mosaicism of aneuploid chromosomes in prenatal diagnosis", J Clin Lab Anal, 34, pp.e23514~ (2020)
- Stipoljev F, "Antenatal detection of mosaic trisomy 9 by ultrasound : a case report and literature review", J Matern Fetal Neonatal Med, 14, pp.65~69 (2003)
- Takahashi H, "Trisomy 9 mosaicism diagnosed in utero", Obstet Gynecol Int, 2010, pp.379534~ (2010)
- Chen CP, "Mosaic trisomy 9 at amniocentesis : prenatal diagnosis and molecular genetic analyses", Taiwan J Obstet Gynecol, 49, pp.341~350 (2010)
- Chen CP, "Prenatal diagnosis of mosaic trisomy 9", Taiwan J Obstet Gynecol, 50, pp.549~553 (2011)
- Merino A, "Prenatal diagnosis of trisomy 9 mosaicism : two new cases", Prenat Diagn, 13, pp.1001~1007 (1993)
- Zhang S, "Application of various genetic analysis techniques for detecting two rare cases of 9p duplication mosaicism during prenatal diagnosis", Mol Genet Genomic Med, 11, pp.e2229~ (2023)